Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., . . . Brown, M. J. (2015). Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial. Lancet.
Stile di citazione ChicagoWilliams, Bryan, et al. "Spironolactone Versus Placebo, Bisoprolol, and Doxazosin to Determine the Optimal Treatment for Drug-resistant Hypertension (PATHWAY-2): A Randomised, Double-blind, Crossover Trial." Lancet 2015.
Citazione MLAWilliams, Bryan, et al. "Spironolactone Versus Placebo, Bisoprolol, and Doxazosin to Determine the Optimal Treatment for Drug-resistant Hypertension (PATHWAY-2): A Randomised, Double-blind, Crossover Trial." Lancet 2015.